体重指数与腰高比变化对心脏代谢风险因素的纵向关联:英国生物银行中的性别特异性分析
基于英国生物银行16911名参与者约4年重复测量数据,分析体重指数(BMI)和腰高比(WHtR)变化与心脏代谢结局的关联。BMI下降≥10%与收缩压、甘油三酯、C反应蛋白等指标改善相关,而BMI增加≥10%则与不良代谢谱相关;BMI与WHtR的关联方向大致相似,部分结局存在非线性及性别差异。
要点
- BMI下降≥10%与收缩压降低6.11 mmHg、甘油三酯降低23.4%、C反应蛋白降低39.5%相关。
- BMI增加≥10%与收缩压升高4.23 mmHg、甘油三酯升高16.9%、C反应蛋白升高45.7%相关。
- BMI与WHtR的关联方向大致相似,部分结局呈非线性且存在性别差异。
核心结论
- 脂肪减少与有利的心脏代谢谱相关,而脂肪增加与不良代谢谱相关;BMI与WHtR的关联方向大致相似,但部分结局和性别间存在差异。
研究设计与样本
- 观察性英国生物银行队列研究,纳入16911名参与者,重复测量人体测量学和生化指标约间隔4年,排除基线心血管疾病、肾衰竭或癌症者,采用多变量协方差分析和限制性立方样条,并对缺失数据多重插补。
主要发现
- 中位随访4.4年,679人BMI下降≥10%,705人BMI增加≥10%;平均基线BMI为26.8 kg/m2(标准差4.5)。
- 与BMI稳定(±5%)相比,BMI下降≥10%与收缩压降低6.11 mmHg(95%CI:−7.14至−5.07)、甘油三酯降低23.4%(95%CI:−25.7至−21.0)、C反应蛋白降低39.5%(95%CI:−43.7至−35.1)相关,并与舒张压、总胆固醇、低密度脂蛋白胆固醇、HbA1c和SCORE2降低及高密度脂蛋白胆固醇升高相关。
- 与BMI稳定(±5%)相比,BMI增加≥10%与收缩压升高4.23 mmHg(95%CI:3.22至5.23)、甘油三酯升高16.9%(95%CI:13.4至20.5)、C反应蛋白升高45.7%(95%CI:36.0至56.1)相关,且大多数结局呈现不利差异。
- BMI和WHtR的关联方向大致相似,部分结局存在非线性。
- 性别修饰了与舒张压、血脂和SCORE2的关联,男性BMI下降时甘油三酯降低幅度更大。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Aims To examine associations of within-person changes in body mass index (BMI) and waist-to-height ratio (WHtR) with cardiometabolic outcomes, characterise dose–response non-linearity and investigate effect modification by sex. Materials and Methods In this observational UK Biobank cohort, participants had repeated anthropometric and biochemical measurements approximately 4 years apart. Those with baseline cardiovascular disease, renal failure or cancer were excluded. Associations of BMI and WHtR change with cardiometabolic outcomes were examined using multivariable analysis of covariance and restricted cubic splines, with multiple imputation for missing data. Results Among 16 911 participants with a mean baseline BMI 26.8 kg/m2 (SD: 4.5), 679 experienced ≥ 10% BMI loss and 705 ≥ 10% gain over median 4.4 years. Compared with stable BMI (±5%), ≥ 10% loss was associated with lower systolic blood pressure (−6.11 mmHg; 95% CI: −7.14 to −5.07), triglycerides (−23.4%; −25.7 to −21.0) and C-reactive protein (−39.5%; −43.7 to −35.1), with lower DBP, total and LDL cholesterol, HbA1c and SCORE2 and higher HDL cholesterol. Conversely, ≥ 10% gain was associated with higher SBP (+4.23 mmHg; 3.22–5.23), triglycerides (+16.9%; 13.4–20.5) and C-reactive protein (+45.7%; 36.0–56.1), with adverse differences across most outcomes. Associations were broadly similar for BMI and WHtR, with non-linearity for selected outcomes. Sex modified associations with DBP, lipids and SCORE2, with larger triglyceride reductions accompanying BMI loss in men. Conclusions Adiposity reduction was associated with favourable cardiometabolic profiles, whereas gain was associated with adverse profiles. BMI and WHtR showed broadly similar directions and patterns of association, with some variation by outcome and sex. These observational associations support prevention of excess adiposity gain and sustained adiposity reduction where clinically appropriate.
引用
- Diabetes, Obesity and Metabolism:Longitudinal Associations of Changes in Body Mass Index and Waist‐to‐Height Ratio With Cardiometabolic Risk Factors: Sex‐Specific Analyses in UK Biobank
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。